Evidence map›Paper›PMID 38117781›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Modulating the sEH/EETs Axis Restrains Specialized Proresolving Mediator Impairment and Regulates T Cell Imbalance in Experimental Periodontitis.

Henrique B Abdalla, Luciano Puhl, Carla Alvarez Rivas, Yu-Chiao Wu, Paola Rojas, Carlos Antonio Trindade-da-Silva, Bruce D Hammock, Krishna R Maddipati, Mariana Q S Soares, Juliana T Clemente-Napimoga and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Henrique B AbdallaDepartment of Applied Oral Sciences, The Forsyth Institute, Cambridge, MA.
Luciano PuhlFaculdade São Leopoldo Mandic, Campinas, Brazil.ORCID 0000-0003-0151-6861
Carla Alvarez RivasDepartment of Applied Oral Sciences, The Forsyth Institute, Cambridge, MA.
Yu-Chiao WuDepartment of Applied Oral Sciences, The Forsyth Institute, Cambridge, MA.
Paola RojasDepartment of Applied Oral Sciences, The Forsyth Institute, Cambridge, MA.
Carlos Antonio Trindade-da-SilvaFaculdade São Leopoldo Mandic, Campinas, Brazil.
Bruce D HammockDepartment of Entomology and UCD Comprehensive Cancer Center, University of California, Davis, CA.
Krishna R MaddipatiDepartment of Pathology, Wayne State University, Detroit, MI.ORCID 0000-0003-1445-791X
Mariana Q S SoaresDepartamento de Radiologia, Faculdade São Leopoldo Mandic, Campinas, Brazil.ORCID 0000-0002-9387-3729
Juliana T Clemente-NapimogaFaculdade São Leopoldo Mandic, Campinas, Brazil.ORCID 0000-0003-1068-3039
Alpdogan KantarciDepartment of Applied Oral Sciences, The Forsyth Institute, Cambridge, MA.
Marcelo H NapimogaFaculdade São Leopoldo Mandic, Campinas, Brazil.ORCID 0000-0003-4472-365X
Thomas E Van DykeDepartment of Applied Oral Sciences, The Forsyth Institute, Cambridge, MA.ORCID 0000-0003-0568-124X
Faculdade São Leopoldo Mandic · BRForsyth Technical Community College · USHarvard University · USUniversity of California, Davis · USWayne State University · US

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Supplement for bioactive lipids as effectors and indicators of the deleterious effects of human healthR35ES030443 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MORISSEAU, CHRISTOPHE HP · 2019 to 2025
$5.8M
Mechanisms of Resolvin E1 in Periodontal RegenerationR01DE025020 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI VAN DYKE, THOMAS ELLIOTT · 2015 to 2023
$4.9M
Linear Ion Trap - Quadrupole LC-MS SystemS10OD032292 · OD · WAYNE STATE UNIVERSITY · PI MADDIPATI, KRISHNARAO · 2022 to 2022
$592k
Triple Quadrupole - Ion Trap Hybrid LC/MS/MS SystemS10RR027926 · NCRR · WAYNE STATE UNIVERSITY · PI MADDIPATI, KRISHNARAO · 2010 to 2010
$425k
NIDCR NIH HHS R01 DE025020NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R35 ES030443
6 · The paper itself

Abstract

Epoxyeicosatrienoic acids (EETs) and other epoxy fatty acids are short-acting lipids involved in resolution of inflammation. Their short half-life, due to its metabolism by soluble epoxide hydrolase (sEH), limits their effects. Specialized proresolving mediators (SPMs) are endogenous regulatory lipids insufficiently synthesized in uncontrolled and chronic inflammation. Using an experimental periodontitis model, we pharmacologically inhibited sEH, examining its impact on T cell activation and systemic SPM production. In humans, we analyzed sEH in the gingival tissue of periodontitis patients. Mice were treated with sEH inhibitor (sEHi) and/or EETs before ligature placement and treated for 14 d. Bone parameters were assessed by microcomputed tomography and methylene blue staining. Blood plasma metabololipidomics were carried out to quantify SPM levels. We also determined T cell activation by reverse transcription-quantitative PCR and flow cytometry in cervical lymph nodes. Human gingival samples were collected to analyze sEH using ELISA and electrophoresis. Data reveal that pharmacological sEHi abrogated bone resorption and preserved bone architecture. Metabololipidomics revealed that sEHi enhances lipoxin A4, lipoxin B4, resolvin E2, and resolvin D6. An increased percentage of regulatory T cells over Th17 was noted in sEHi-treated mice. Lastly, inflamed human gingival tissues presented higher levels and expression of sEH than did healthy gingivae, being positively correlated with periodontitis severity. Our findings indicate that sEHi preserves bone architecture and stimulates SPM production, associated with regulatory actions on T cells favoring resolution of inflammation. Because sEH is enhanced in human gingivae from patients with periodontitis and connected with disease severity, inhibition may prove to be an attractive target for managing osteolytic inflammatory diseases.

Indexed as

Bone ResorptionPeriodontitisAnimalsEicosanoidsEpoxide HydrolasesHumansInflammationMiceX-Ray MicrotomographyEicosanoidsEpoxide Hydrolases

Identifiers

PMID38117781
PMCPMC10866374
OpenAlexW4389990995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.